However, dosing regimens, administration routes, and treatment durations vary considerably across these studies, making direct comparisons challenging (Pickart & Margolina, 2018)
Ozempic (Semaglutide) Ozempic sales in 2022: $8.713 billion Company/Developer: Novo Nordisk Date of first FDA approval: December 5, 2017 Indications Ozempic is FDA-approved for: Type 2 diabetes Price of Ozempic: $1,029 for 1.5 mL subcutaneous solution (2 mg/1.5 mL (0.25 mg or 0.5 mg dose)) Why it did so well: Ozempic is a glucagon-like peptide 1 (GLP-1) receptor agonist used for the treatment of adults with type 2 diabetes as an adjunct to diet and exercise to improve glycemic control
Lustig elucidates how fructose manipulates our brain's reward system, drawing parallels between sugar craving and drug dependence
doi: 10.1210/endo.142.6.8198 47 HeSYeZDobbelaarPHBakshiRKHongQDellureficioJPet al
Liver pain often does not occur in isolation
Endocr J 62:971980 Degn KB, Juhl CB, Sturis J et al (2004) One weeks treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes
